In his weekly clinical update, Daniel Griffin and Vincent Racaniello are cautiously elated by results of election day 2026 on the backdrop of additional measles associated deaths in Wisconsin, Pennsylvania and New York, return of mpox, Chagas disease in Texas, hippopotami dying from anthrax infections, increase in dengue cases in Florida before Dr. Griffin deep dives into recent statistics RSV, influenza, SARS-CoV-2 infections and measles, susceptibility of human neural stem cells to SARS-CoV-2 infection, chemosensory dysfunction after COVID-19 vaccination, low dose naltrexone for Post-COVID Fatigue Syndrome, effect of metformin at the time of SARS-CoV-2 infection and the FDA approved package inserts for the influenza and COVID-19 mRNA vaccines.
Pennsylvania Department of Health Confirms Sixth Measles-Associated Death, Provides Statewide Update on Measles Outbreak as Cases Reach 1,467 in 45 Counties (Pennsylvaina Department of Health)
DHS Reports a Death Connected to the Ongoing MeaslesOutbreak (Wisconsin Department of Health Services)
A baby in Wisconsin has died from measles, the 3rd such US death this week (CIDRAP)
Four Mpox Cases reported to Stanislaus County Public Health (Stanislaus County: California)
Autochthonous Acute Chagas Disease with Fulminant Myocarditis in a Texas Infant Exposed to a Peridomestic Environment with Trypanosoma cruzi-infected Vectors and Animals (CID)
Mysterious anthrax outbreak kills hippos in Africa — raising concerns for human spread (Nature)
Pennsylvania Department of Health Confirms Sixth Measles-Associated Death, Provides Statewide Update on Measles Outbreak as Cases Reach 1,467 in 45 Counties (Pennsylvaina Department of Health)
Susceptibility of human neural stem cells to SARS-CoV-2: Entry mechanisms and glycocalyx influence (PLos One)
Comparing the Risk of Maternal Complications and Adverse Infant Outcomes Among Pregnancies With and Without COVID-19 in the Sentinel System (PDS: Pharmacoepidemiology & Drug Safety)
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts (NEJM)
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines (Moderna)
Novavax’s Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season (Novavax)
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine (Pfizer)
Podden och tillhörande omslagsbild på den här sidan tillhör
Vincent Racaniello. Innehållet i podden är skapat av Vincent Racaniello och inte av,
eller tillsammans med, Poddtoppen.
